Skip to main content

Written question asked by Norman Baker (Liberal Democrat) on Tuesday, 20 April 2004, in the House of Commons. It was due for an answer on Wednesday, 28 April 2004. It was answered by Ben Bradshaw (Labour) on Wednesday, 28 April 2004 on behalf of the Department for Environment, Food and Rural Affairs.


Dept for Environment Food and Rural Affairs

Question
To ask the Secretary of State for Environment, Food and Rural Affairs, what work has been carried out to establish the background levels of fluoxetine in the aquatic environment;what information she has procured to establish the levels of residues from anti-depressant drugs in the (a) livers, (b0 brains and (c) muscle of fish. (Holding answer 23 April 2004).
Answer

Norman Baker: To ask the Secretary of State for Environment, Food and Rural Affairs (1) what work has been carried out to establish the background levels of fluoxetine in the aquatic environment; [167861] (2) what information she has procured to establish the levels of residues from anti-depressant drugs in the (a) livers, (b) brains and (c) muscle of fish. Mr. Bradshaw: [holding answer 23 April 2004]: During 2002-03 the Environment Agency carried out a desk based ranking exercise on the 500 pharmaceuticals most commonly used in England and Wales in order to prioritise those of environmental significance. This exercise included fluoxetine, more commonly known under the trade name Prozac. A short, targeted monitoring programme was then set up for 12 pharmaceuticals. Fluoxetine was not included because no analytical method suitable for use on environmental samples existed and development of one would be difficult. The top ranked antidepressant was lofepramine and this was included in the monitoring survey. A method was not in existence and had to be developed. Lofepramine was not detected in any of the five sewage works effluents or receiving watercourses monitored. However, it does not necessarily follow that the same would be true for fluoxetine. No monitoring of fish has been undertaken. The Environment Agency have developed a Position Statement on pharmaceuticals--which can be found on the Agency's website, www.environment-agency.gov.uk (search--pharmaceuticals). This elaborates further on the work done and includes a recommendation to the pharmaceutical industry to do more on the development of analytical methods for environmental monitoring. I am pleased that the Environment Agency is in discussion with the industry on the development of a work programme to cover the recommendations to industry listed in the Position Statement.


Secondary information

Type
Written question
Reference
420 c1014-5W; 167861;167860
Session
2003-04
Subjects
Environment Drugs Fish Pollution Monitoring Research Seas and oceans Antidepressants Fluoxetine
Link
View this Written question on www.publications.parliament.uk